title: Hepatitis B surface antigen clearance and appearance of antibodies against hepatitis B surface antigen after treatment with recombinant interleukin 2 in a human immunodeficiency virus-infected patient.
authors.forename: N
authors.initials: N
authors.lastname: Gianotti
authors.forename: C
authors.initials: C
authors.lastname: Uberti-Foppa
authors.forename: E
authors.initials: E
authors.lastname: Boeri
authors.forename: M
authors.initials: M
authors.lastname: Marinelli
authors.forename: G
authors.initials: G
authors.lastname: Tambussi
authors.forename: R
authors.initials: R
authors.lastname: Finazzi
authors.forename: A
authors.initials: A
authors.lastname: Lazzarin
mesh_terms: D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology*; D006508:Hepatitis Antibodies / Q000032:analysis* / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000032:analysis* / Q000276:immunology; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D006508:Hepatitis Antibodies; D006514:Hepatitis B Surface Antigens; D007376:Interleukin-2; D011994:Recombinant Proteins